SOLVAR LIMITED (SVR)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SVR

SVR - SOLVAR LIMITED

FNArena Sector : Business & Consumer Credit
Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: 7.24
Index: ALL-ORDS

0

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.74

25 Aug
2026

0.025

OPEN

$1.73

1.46%

HIGH

$1.74

105,262

LOW

$1.72

TARGET
$1.78 2.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
BTN . CCP . CCV . CGR . COG . EML . EPY . FND . FSA . HUM . JDO . LFS . MME . PGL . PLT . PNC . PPM . QAL . SIV . TYR . WZR . XYZ . ZIP .
FNARENA'S MARKET CONSENSUS FORECASTS
SVR: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx 15.5 19.0 xxx
DPS (cps) xxx 0.0 17.0 xxx
EPS Growth xxx 0.1% 22.6% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 9.1 xxx
Dividend Yield xxx N/A 9.9% xxx
Div Pay Ratio(%) xxx N/A 89.5% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/03 - ex-div 6.00c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx15.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx193.4 M
Book Value Per Share xxxxxxxxxxxxxxx174.2
Net Operating Cash Flow xxxxxxxxxxxxxxx-24.2 M
Net Profit Margin xxxxxxxxxxxxxxx15.24 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx8.63 %
Return on Invested Capital xxxxxxxxxxxxxxx4.26 %
Return on Assets xxxxxxxxxxxxxxx2.96 %
Return on Equity xxxxxxxxxxxxxxx8.63 %
Return on Total Capital xxxxxxxxxxxxxxx9.50 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-60.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx189 M
Long Term Debt xxxxxxxxxxxxxxx493 M
Total Debt xxxxxxxxxxxxxxx682 M
Goodwill - Gross xxxxxxxxxxxxxxx19 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx120 M
Price To Book Value xxxxxxxxxxxxxxx0.85

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx0.2 M
Capex % of Sales xxxxxxxxxxxxxxx0.13 %
Cost of Goods Sold xxxxxxxxxxxxxxx15 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx86 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx8 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

20/08/2026

2

Accumulate

$1.78

2.30%

Morgans retains an Accumulate rating for Solvar with a price target of $1.78 per share following a solid FY26 result that tracked broadly in line with expectations.

The group delivered a normalised net profit after tax of $36.1m, matching guidance of $36.0m, while continuing to execute an orderly exit from New Zealand operations.

The gross loan book expanded 4.8% year-on-year to $953.4m, outperforming the broker's $929m forecast, led by strong Australian receivables growth.

Positive origination momentum observed in the second half of FY26 has carried forward into early FY27, supporting the broader commercial push and book growth objectives.

The analyst notes that net interest income of $145.7m contracted 6% year-on-year due to lower New Zealand income contributions.

FORECAST
Morgans forecasts a full year FY27 dividend of 17.00 cents and EPS of 19.00 cents.
Morgans forecasts a full year FY28 dividend of 18.00 cents and EPS of 21.00 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Shaw and Partners

21/08/2026

1

Initiation of coverage with Buy

$1.90

9.20%

Shaw and Partners initiates coverage of Solvar with a Buy rating and a 12-month target price of $1.90 following the conclusion of its ASIC litigation and the strategic wind-down of its unprofitable New Zealand loan book.

The analyst highlights that loan balance expansion across the Money3, AFS, and bennji operating platforms should drive over 25% cash net profit after tax growth in FY28 as total loan balances approach $1.2bn.

The business benefits from strong distribution through more than 1,600 brokers, over $400m in undrawn funding headroom, and robust collection processes that maintain high asset quality.

Shaw believes the stock offers an attractive fully franked dividend yield exceeding 8% supported by disciplined capital management.

FORECAST
Shaw and Partners forecasts a full year FY27 dividend of 13.00 cents and EPS of 15.50 cents.
Shaw and Partners forecasts a full year FY28 dividend of 15.00 cents and EPS of 20.40 cents.

SVR STOCK CHART